Thermo Fisher Provides Notice on Convertible Debentures | GenomeWeb

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today provided notice to holders of certain bonds have the right to convert the debentures.

The firm said that holders of Apogent Technologies' Floating Rate Convertible Senior Debentures due 2033 may convert the debentures because Thermo Fisher's stock has traded above the minimum price specified in the indenture over the applicable measurement period.

Thermo Fisher assumed the debentures as part of its acquisition of Apogent in 2004.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."